Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > and this is why You are here;)

<< Previous

Bullboard Posts

Next >>

Comment by GunnerGon May 29, 2020 10:42am

70 Views

Post# 31087447

RE:RE:and this is why You are here;)

Newcamo, did you dig up the information?

GunnerG wrote: Newcamo, please post the NR or the transcript where LMNL actually said "as been tested running in plant for 6 months, its a success." and where "They met the FDA to submit ".

I remember it differently than you have posted, so I, along with others, would like to reread what LMNL actually said.

You have misrepresented LMNL's comments in the past. (it has always been H1 2020. When H1 2020 was the pushed out date.)